Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Copper kinetics in liver disease.

R A Smallwood, B McIlveen, V M Rosenoer

    Gut
    |February 1, 1971
    PubMed
    Summary
    This summary is machine-generated.

    Patients with Wilson's disease show impaired copper (64Cu) transport, affecting plasma clearance and liver uptake. This defect is specific to Wilson's disease, not just high copper levels or general liver dysfunction.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis.

    Journal of hepatology·2001
    Same author

    Neonatal hepatic drug elimination.

    Pharmacology & toxicology·2001
    Same author

    Learning from adverse events.

    International journal for quality in health care : journal of the International Society for Quality in Health Care·2000
    Same author

    Right heart failure impairs hepatic elimination of p-nitrophenol without inducing changes in content or latency of hepatic UDP-glucuronosyltransferases.

    The Journal of pharmacology and experimental therapeutics·2000
    Same author

    Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity.

    Drug metabolism and disposition: the biological fate of chemicals·2000
    Same author

    Risk of gastric cancer is not increased after partial gastrectomy.

    Journal of gastroenterology and hepatology·2000

    Area of Science:

    • Hepatology
    • Medical Imaging
    • Biochemistry

    Background:

    • Wilson's disease is a genetic disorder characterized by excessive copper accumulation in organs, primarily the liver.
    • Copper transport abnormalities are central to Wilson's disease pathogenesis.
    • Understanding copper kinetics is crucial for diagnosing and managing Wilson's disease.

    Purpose of the Study:

    • To investigate the in vivo kinetics of copper (64Cu) transport in patients with Wilson's disease.
    • To differentiate copper transport defects in Wilson's disease from other liver conditions with elevated copper.
    • To explore the role of hepatic uptake and plasma clearance in Wilson's disease pathophysiology.

    Main Methods:

    • Intravenous administration of radioactive copper isotope (64Cu).

    Related Experiment Videos

  • Measurement of plasma clearance rates of 64Cu.
  • Quantification of hepatic uptake of 64Cu using imaging techniques.
  • Comparison of copper kinetics in Wilson's disease patients with those in primary biliary cirrhosis and other hepatocellular diseases.

    • Main Results:

    • Significantly impaired plasma clearance and liver uptake of 64Cu were observed in Wilson's disease patients.
    • Normal 64Cu plasma clearance and hepatic uptake were found in patients with primary biliary cirrhosis and other hepatocellular diseases, despite comparable liver copper levels.
    • These findings suggest a specific defect in copper transport unique to Wilson's disease.

    Conclusions:

    • The study identifies a specific impairment in copper (64Cu) plasma clearance and liver uptake in Wilson's disease.
    • The observed defects are distinct from those caused by generalized high liver copper or impaired liver cell function.
    • Further research is needed to elucidate the precise molecular mechanisms of copper transport defects in Wilson's disease, potentially involving hepatic lysosomes.